Objective

Primary cells are essential every step of the way in the development of new therapeutics. Whether you are performing phenotypic screening, in vitro-assays, or preparing cells for Next-Generation Sequencing, pure and viable cells are crucial for the success of bioassays. We present novel methods of isolating primary cells from Leukopak, buffy coat and LRSC in a fast, gentle and fully automated manner.